Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses
- 1 November 1999
- journal article
- review article
- Published by Wiley in Teratology
- Vol. 60 (5), 306-321
- https://doi.org/10.1002/(sici)1096-9926(199911)60:5<306::aid-tera11>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Was tumour necrosis factor-α responsible for the fetal malformations associated with thalidomide in the early 1960s?Medical Hypotheses, 1998
- Inflammatory Bowel Disease ManagementDrugs, 1997
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- EditorialReproductive Toxicology, 1996
- Thalidomide and Its Metabolites Have No Effect on Human Lymphocyte ProliferationInternational Archives of Allergy and Immunology, 1996
- Thalidomide derivatives and the immune system 6. Effects of two derivatives with no obvious teratogenic potency on the pattern of integrins and other surface receptors on blood cells of marmosetsLife Sciences, 1995
- Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomideLife Sciences, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Thalidomide for systemic lupus erythematosusThe Lancet, 1992
- Thalidomide for systemic lupus erythematosusThe Lancet, 1992